These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 29648740)

  • 1. Impact of a value-based formulary in three chronic disease cohorts.
    Yeung K; Basu A; Marcum ZA; Watkins JB; Sullivan SD
    Am J Manag Care; 2017 Mar; 23(3 Suppl):S46-S53. PubMed ID: 29648740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of a Value-based Formulary on Medication Utilization, Health Services Utilization, and Expenditures.
    Yeung K; Basu A; Hansen RN; Watkins JB; Sullivan SD
    Med Care; 2017 Feb; 55(2):191-198. PubMed ID: 27579915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of a value-based insurance design plus health coaching on medication adherence and medical spending.
    Musich S; Wang S; Hawkins K
    Popul Health Manag; 2015 Jun; 18(3):151-8. PubMed ID: 25247449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug use and spending under a formulary informed by cost-effectiveness.
    Yeung K; Cruz M; Tsiao E; Watkins JB; Sullivan SD
    J Manag Care Spec Pharm; 2023 Nov; 29(11):1175-1183. PubMed ID: 37889867
    [No Abstract]   [Full Text] [Related]  

  • 5. Impact of a transition to more restrictive drug formulary on therapy discontinuation and medication adherence.
    Shirneshan E; Kyrychenko P; Matlin OS; Avila JP; Brennan TA; Shrank WH
    J Clin Pharm Ther; 2016 Feb; 41(1):64-9. PubMed ID: 26778812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between dispensing channel and medication adherence among medicare beneficiaries taking medications to treat diabetes, high blood pressure, or high blood cholesterol.
    Iyengar RN; Balagere DS; Henderson RR; LeFrancois AL; Rabbitt RM; Frazee SG
    J Manag Care Spec Pharm; 2014 Aug; 20(8):851-61. PubMed ID: 25062079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Designing a Value-Based Formulary for a Commercial Health Plan: A Simulated Case Study of Diabetes Medications.
    Chen Y; Loucks AR; Sullivan SD; Pearson SD; Kent D; Yeung K
    Value Health; 2023 Jul; 26(7):1022-1031. PubMed ID: 36796479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of increased adherence and cost savings of an employer value-based benefits program targeting generic antihyperlipidemic and antidiabetic medications.
    Clark B; DuChane J; Hou J; Rubinstein E; McMurray J; Duncan I
    J Manag Care Pharm; 2014 Feb; 20(2):141-50. PubMed ID: 24456315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of the Medicare Part D coverage gap on medication use among patients with hypertension and hyperlipidemia.
    Li P; McElligott S; Bergquist H; Schwartz JS; Doshi JA
    Ann Intern Med; 2012 Jun; 156(11):776-84, W-263, W-264, W-265, W-266, W-267, W-268, W-269. PubMed ID: 22665815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, implementation, and first-year outcomes of a value-based drug formulary.
    Sullivan SD; Yeung K; Vogeler C; Ramsey SD; Wong E; Murphy CO; Danielson D; Veenstra DL; Garrison LP; Burke W; Watkins JB
    J Manag Care Spec Pharm; 2015 Apr; 21(4):269-75. PubMed ID: 25803760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increasing copayments and adherence to diabetes, hypertension, and hyperlipidemic medications.
    Maciejewski ML; Bryson CL; Perkins M; Blough DK; Cunningham FE; Fortney JC; Krein SL; Stroupe KT; Sharp ND; Liu CF
    Am J Manag Care; 2010 Jan; 16(1):e20-34. PubMed ID: 20059288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prescription co-pay reduction program for diabetic employees.
    Nair KV; Miller K; Park J; Allen RR; Saseen JJ; Biddle V
    Popul Health Manag; 2010 Oct; 13(5):235-45. PubMed ID: 20879904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of 3-tier formularies on drug treatment of attention-deficit/hyperactivity disorder in children.
    Huskamp HA; Deverka PA; Epstein AM; Epstein RS; McGuigan KA; Muriel AC; Frank RG
    Arch Gen Psychiatry; 2005 Apr; 62(4):435-41. PubMed ID: 15809411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of a Remotely Delivered Tailored Multicomponent Approach to Enhance Medication Taking for Patients With Hyperlipidemia, Hypertension, and Diabetes: The STIC2IT Cluster Randomized Clinical Trial.
    Choudhry NK; Isaac T; Lauffenburger JC; Gopalakrishnan C; Lee M; Vachon A; Iliadis TL; Hollands W; Elman S; Kraft JM; Naseem S; Doheny S; Lee J; Barberio J; Patel L; Khan NF; Gagne JJ; Jackevicius CA; Fischer MA; Solomon DH; Sequist TD
    JAMA Intern Med; 2018 Sep; 178(9):1182-1189. PubMed ID: 30083727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of drug plans on adherence to and the cost of antihypertensive medications among patients covered by a universal drug insurance program.
    Després F; Perreault S; Lalonde L; Forget A; Kettani FZ; Blais L
    Can J Cardiol; 2014 May; 30(5):560-7. PubMed ID: 24613090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of a Combined Value-Based Insurance Design and Medication Therapy Management Program on Diabetes Medication Adherence.
    Peaslee A; Wickizer M; Olson J; Topp R
    J Manag Care Spec Pharm; 2016 Nov; 22(11):1303-1309. PubMed ID: 27783550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cost and effectiveness of adherence-improving interventions for antihypertensive and lipid-lowering drugs*.
    Chapman RH; Ferrufino CP; Kowal SL; Classi P; Roberts CS
    Int J Clin Pract; 2010 Jan; 64(2):169-81. PubMed ID: 20089007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medication adherence star ratings measures, health care resource utilization, and cost.
    Poonawalla IB; Chung L; Shetler S; Pearce H; Dixon SW; Racsa P
    Am J Manag Care; 2024 May; 30(5):210-217. PubMed ID: 38748928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of value-based benefit design on adherence to diabetes medications: a propensity score-weighted difference in difference evaluation.
    Zeng F; An JJ; Scully R; Barrington C; Patel BV; Nichol MB
    Value Health; 2010; 13(6):846-52. PubMed ID: 20561344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of primary care intensive management on medication adherence and adjustments.
    Yoon J; Wu F; Chang E
    Am J Manag Care; 2020 Aug; 26(8):e239-e245. PubMed ID: 32835465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.